Apogee (APOG) Q3 2026 Earnings Call Transcript
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 07 2026
0mins
Should l Buy APOG?
Source: NASDAQ.COM
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy APOG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on APOG
Wall Street analysts forecast APOG stock price to rise
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 41.420
Low
44.00
Averages
45.00
High
46.00
Current: 41.420
Low
44.00
Averages
45.00
High
46.00
About APOG
Apogee Enterprises, Inc. is a provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used for preservation, energy conservation, and enhanced viewing. Its segments include Architectural Metals, Architectural Services, Architectural Glass and Performance Surfaces. The Architectural Metals segment designs, engineers, fabricates and finishes aluminum window, curtainwall, storefront and entrance systems used primarily in non-residential construction. Architectural Services segment integrates technical services, project management, and field installation services to design, engineer, fabricate, and install architectural curtainwall and other facade-related systems primarily in non-residential construction. The Architectural Glass segment cuts, treats, coats and fabricates high-performance glass used in custom window and wall systems. The Performance Surfaces segment develops and manufactures high-performance coated materials.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Pomerantz LLP Investigates Apogee Securities Fraud Claims
- Disappointing Financial Performance: Apogee Enterprises reported $355.3 million in sales for Q3 of its 2026 fiscal year, falling short of the consensus estimate of $348.6 million, indicating significant cost pressures that could undermine investor confidence.
- Significant Stock Decline: Following the disappointing earnings report, Apogee's stock price plummeted by $5.18, or 13.89%, closing at $32.11 per share on January 7, 2026, reflecting market concerns about the company's future performance.
- Investigation Launched: Pomerantz LLP is investigating whether Apogee and its executives engaged in securities fraud or other unlawful business practices, which could lead to further legal repercussions and impact the company's reputation and shareholder interests.
- Legal Context: Pomerantz LLP, recognized as a leading firm in securities class action litigation, has successfully recovered millions in damages for victims of securities fraud, underscoring its significant capability and influence in handling such cases.
See More
Investigation into Securities Fraud Claims Against Apogee Enterprises
- Poor Financial Performance: Apogee reported $355.3 million in sales for Q3 of fiscal 2026 on January 7, 2025, missing the consensus estimate of $348.6 million, indicating challenges in cost management, particularly due to rising aluminum, restructuring, and health insurance costs.
- Significant Stock Decline: Following the earnings report, Apogee's stock price fell by $5.18, or 13.89%, closing at $32.11 per share on January 7, 2026, which may lead to decreased investor confidence and impact the company's future financing capabilities.
- Legal Investigation Initiated: Pomerantz LLP is investigating claims against Apogee and its executives regarding potential securities fraud or other unlawful business practices, which could expose the company to legal liabilities and potential damages.
- Increased Investor Attention: As the investigation unfolds, investors are encouraged to contact Pomerantz LLP, reflecting a growing market concern regarding corporate governance and transparency, which may affect Apogee's reputation and market performance.
See More
Investigation into Securities Fraud Claims Against Apogee Enterprises
- Financial Performance Decline: Apogee reported $355.3 million in sales for Q3 of fiscal 2026, missing the consensus estimate of $348.6 million, indicating a decline in profitability under cost pressures that may affect future investor confidence.
- Significant Stock Price Drop: Following the disappointing earnings report, Apogee's stock price fell by $5.18, or 13.89%, closing at $32.11 per share on January 7, 2026, reflecting market concerns over the company's financial health.
- Legal Investigation Initiated: Pomerantz LLP is investigating claims of securities fraud against Apogee and its executives, advising investors to contact the firm for information on joining the class action, which could expose the company to legal liabilities and financial repercussions.
- Cost Pressure Factors: Apogee's CEO cited rising aluminum prices, restructuring, and health insurance costs as key contributors to the poor performance, factors that not only impact current financial results but may also have far-reaching implications for the company's long-term strategy and operational model.
See More
Apogee Enterprises Appoints Mark Augdahl as CFO, Raises FY2026 EPS Outlook to $3.40-$3.50
- Executive Appointment: Apogee Enterprises has appointed Mark Augdahl as Executive Vice President and Chief Financial Officer effective immediately, having served as interim CFO since January 7, 2026, ensuring continuity and stability in financial management.
- Earnings Outlook Upgrade: Amid aluminum cost pressures, Apogee has updated its fiscal 2026 EPS outlook to $3.40-$3.50, reflecting the company's ability to maintain profitability despite challenges and enhancing investor confidence.
- Project Expansion: Apogee continues to expand Project Fortify Phase 2 despite aluminum cost pressures, indicating ongoing efforts to optimize operations and control costs, aimed at improving overall business efficiency.
- Market Reaction: The executive change and earnings outlook upgrade are likely to positively impact Apogee's stock price, boosting market confidence in its future growth potential.
See More
Apogee Enterprises Under Investigation After Q3 Sales Miss Estimates
- Financial Performance Decline: Apogee reported $355.3 million in sales for Q3 of fiscal 2026, falling short of the consensus estimate of $348.6 million, indicating significant performance issues under cost pressures.
- Stock Price Plummet: Following the disappointing earnings report, Apogee's stock price dropped by $5.18, or 13.89%, closing at $32.11 per share on January 7, 2026, reflecting investor concerns about the company's outlook.
- Investigation Launched: Pomerantz LLP is investigating whether Apogee and its executives engaged in securities fraud or other unlawful business practices, which could negatively impact the company's reputation and future operations.
- Significant Cost Pressures: The CEO highlighted that rising aluminum prices, restructuring, and health insurance costs were major factors contributing to the poor performance, potentially affecting the company's long-term profitability and market competitiveness.
See More
Apogee (APOG) Declares $0.27 Quarterly Dividend, 3.8% Increase
- Dividend Increase: Apogee has declared a quarterly dividend of $0.27 per share, marking a 3.8% increase from the previous $0.26, reflecting the company's ongoing commitment to stable cash flow and shareholder returns.
- Yield Insight: The forward yield of this dividend stands at 3.04%, providing investors with a relatively attractive return, thereby enhancing market confidence in Apogee's stock.
- Payment Details: The dividend is payable on February 18, with a record date of February 3 and an ex-dividend date also set for February 3, ensuring shareholders receive their earnings promptly.
- Financial Outlook: Apogee has updated its fiscal 2026 EPS outlook to a range of $3.40 to $3.50, demonstrating resilience in project advancement and financial management despite aluminum cost pressures.
See More
Pomerantz LLP Investigates Apogee Securities Fraud Claims
- Disappointing Financial Performance: Apogee Enterprises reported $355.3 million in sales for Q3 of its 2026 fiscal year, falling short of the consensus estimate of $348.6 million, indicating significant cost pressures that could undermine investor confidence.
- Significant Stock Decline: Following the disappointing earnings report, Apogee's stock price plummeted by $5.18, or 13.89%, closing at $32.11 per share on January 7, 2026, reflecting market concerns about the company's future performance.
- Investigation Launched: Pomerantz LLP is investigating whether Apogee and its executives engaged in securities fraud or other unlawful business practices, which could lead to further legal repercussions and impact the company's reputation and shareholder interests.
- Legal Context: Pomerantz LLP, recognized as a leading firm in securities class action litigation, has successfully recovered millions in damages for victims of securities fraud, underscoring its significant capability and influence in handling such cases.
See More
Investigation into Securities Fraud Claims Against Apogee Enterprises
- Poor Financial Performance: Apogee reported $355.3 million in sales for Q3 of fiscal 2026 on January 7, 2025, missing the consensus estimate of $348.6 million, indicating challenges in cost management, particularly due to rising aluminum, restructuring, and health insurance costs.
- Significant Stock Decline: Following the earnings report, Apogee's stock price fell by $5.18, or 13.89%, closing at $32.11 per share on January 7, 2026, which may lead to decreased investor confidence and impact the company's future financing capabilities.
- Legal Investigation Initiated: Pomerantz LLP is investigating claims against Apogee and its executives regarding potential securities fraud or other unlawful business practices, which could expose the company to legal liabilities and potential damages.
- Increased Investor Attention: As the investigation unfolds, investors are encouraged to contact Pomerantz LLP, reflecting a growing market concern regarding corporate governance and transparency, which may affect Apogee's reputation and market performance.
See More
Investigation into Securities Fraud Claims Against Apogee Enterprises
- Financial Performance Decline: Apogee reported $355.3 million in sales for Q3 of fiscal 2026, missing the consensus estimate of $348.6 million, indicating a decline in profitability under cost pressures that may affect future investor confidence.
- Significant Stock Price Drop: Following the disappointing earnings report, Apogee's stock price fell by $5.18, or 13.89%, closing at $32.11 per share on January 7, 2026, reflecting market concerns over the company's financial health.
- Legal Investigation Initiated: Pomerantz LLP is investigating claims of securities fraud against Apogee and its executives, advising investors to contact the firm for information on joining the class action, which could expose the company to legal liabilities and financial repercussions.
- Cost Pressure Factors: Apogee's CEO cited rising aluminum prices, restructuring, and health insurance costs as key contributors to the poor performance, factors that not only impact current financial results but may also have far-reaching implications for the company's long-term strategy and operational model.
See More
Apogee Enterprises Appoints Mark Augdahl as CFO, Raises FY2026 EPS Outlook to $3.40-$3.50
- Executive Appointment: Apogee Enterprises has appointed Mark Augdahl as Executive Vice President and Chief Financial Officer effective immediately, having served as interim CFO since January 7, 2026, ensuring continuity and stability in financial management.
- Earnings Outlook Upgrade: Amid aluminum cost pressures, Apogee has updated its fiscal 2026 EPS outlook to $3.40-$3.50, reflecting the company's ability to maintain profitability despite challenges and enhancing investor confidence.
- Project Expansion: Apogee continues to expand Project Fortify Phase 2 despite aluminum cost pressures, indicating ongoing efforts to optimize operations and control costs, aimed at improving overall business efficiency.
- Market Reaction: The executive change and earnings outlook upgrade are likely to positively impact Apogee's stock price, boosting market confidence in its future growth potential.
See More
Apogee Enterprises Under Investigation After Q3 Sales Miss Estimates
- Financial Performance Decline: Apogee reported $355.3 million in sales for Q3 of fiscal 2026, falling short of the consensus estimate of $348.6 million, indicating significant performance issues under cost pressures.
- Stock Price Plummet: Following the disappointing earnings report, Apogee's stock price dropped by $5.18, or 13.89%, closing at $32.11 per share on January 7, 2026, reflecting investor concerns about the company's outlook.
- Investigation Launched: Pomerantz LLP is investigating whether Apogee and its executives engaged in securities fraud or other unlawful business practices, which could negatively impact the company's reputation and future operations.
- Significant Cost Pressures: The CEO highlighted that rising aluminum prices, restructuring, and health insurance costs were major factors contributing to the poor performance, potentially affecting the company's long-term profitability and market competitiveness.
See More
Apogee (APOG) Declares $0.27 Quarterly Dividend, 3.8% Increase
- Dividend Increase: Apogee has declared a quarterly dividend of $0.27 per share, marking a 3.8% increase from the previous $0.26, reflecting the company's ongoing commitment to stable cash flow and shareholder returns.
- Yield Insight: The forward yield of this dividend stands at 3.04%, providing investors with a relatively attractive return, thereby enhancing market confidence in Apogee's stock.
- Payment Details: The dividend is payable on February 18, with a record date of February 3 and an ex-dividend date also set for February 3, ensuring shareholders receive their earnings promptly.
- Financial Outlook: Apogee has updated its fiscal 2026 EPS outlook to a range of $3.40 to $3.50, demonstrating resilience in project advancement and financial management despite aluminum cost pressures.
See More
